)
)
Alterity Therapeutics Investor Relations Material
Latest events
Study Update
Alterity Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Alterity Therapeutics Limited
Access all reports
Alterity Therapeutics Limited is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company specializes in small molecule treatments designed to target underlying biological processes associated with disorders such as Parkinsons and other neurological conditions. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for Alterity Therapeutics Limited
Corporate Presentation
Alterity Therapeutics Limited
Corporate Presentation
Alterity Therapeutics Limited
Latest articles
)
Axon: Making Bullets Obsolete
Axon transformed the TASER from a struggling invention into a $50B public safety giant, redefining policing with tech-driven solutions.
21 Feb 2025
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
Ticker symbol
ATH
Country
🇦🇺 Australia